Top compounds associated with response to TMEM8B


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA RAF265 CCLE pan-cancer AAC -0.15 0.003
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.15 0.003
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA PI-103 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.16 0.003
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.11 0.004
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA FH535 GDSC1000 pan-cancer AAC -0.098 0.004
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.15 0.005
Download CSV